FBInvestor
Stocks / Moonlake Immunotherapeutics
Institutional Ownership

Moonlake Immunotherapeutics

CUSIP 61559X954PUTMLTXQ1 2026

No Form 4 insider transactions ingested yet

Insider (Form 4) filings for Moonlake Immunotherapeutics are fetched from SEC EDGAR on a rolling basis. Check back shortly.